Featured Content by Angelina Collins
Webcast: UC: Case Based Guideline and Positioning Review with Angelina Collins
In this IBD Community Network case-based discussion, Angelina Collins, NP, from UC San Diego reviews how healthcare professionals can evaluate and manage moderate-to-severe ulcerative colitis. Using a patient with persistent symptoms despite corticosteroids, mesalamine, and adalimumab, the session explores the differences between ulcerative colitis and Crohn’s disease, IBD diagnosis, disease phenotypes, poor prognostic factors, and measures of disease activity—including stool frequency, rectal bleeding, fecal calprotectin, CRP, colonoscopy findings, and the Mayo endoscopic score.
The presentation also examines evidence-based ulcerative colitis treatment selection, AGA and ACG guidelines, therapy sequencing after anti-TNF exposure, steroid-sparing strategies, biomarker monitoring, repeat colonoscopy, and shared decision-making. Viewers will gain practical insights into recognizing an inadequate treatment response, selecting appropriately effective therapy early, and reducing the risks associated with ongoing inflammation, hospitalization, surgery, colorectal cancer, and other complications of uncontrolled ulcerative colitis.
Visit the IBD Community Network for more educational resources related to IBD care.
Learn More